Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism
- PMID: 29959155
- DOI: 10.1136/bmjebm-2018-111007
Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231094 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources